196 related articles for article (PubMed ID: 25336127)
1. [Rapid detection of BCHE atypical variant (p.Asp70Gly) by high resolution melting curve analysis].
Mabboux I; Dos Santos M; Courcelle S; Hary B; Ceppa F; Delacour H
Ann Biol Clin (Paris); 2014; 72(5):543-8. PubMed ID: 25336127
[TBL] [Abstract][Full Text] [Related]
2. Butyrylcholinesterase deficiency.
Delacour H; Dedome E; Courcelle S; Hary B; Ceppa F
Ann Biol Clin (Paris); 2016 Jun; 74(3):279-85. PubMed ID: 27237801
[TBL] [Abstract][Full Text] [Related]
3. [Prolonged neuromuscular block in a patient with butyrylcholinesterase deficiency].
Mabboux I; Hary B; Courcelle S; Ceppa F; Delacour H
Arch Pediatr; 2016 May; 23(5):497-500. PubMed ID: 27017361
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.
Delacour H; Lushchekina S; Mabboux I; Bousquet A; Ceppa F; Schopfer LM; Lockridge O; Masson P
PLoS One; 2014; 9(7):e101552. PubMed ID: 25054547
[TBL] [Abstract][Full Text] [Related]
5. A novel mutation in the BCHE gene and phenotype identified in a child with low butyrylcholinesterase activity: a case report.
Yu R; Guo Y; Dan Y; Tan W; Mao Q; Deng G
BMC Med Genet; 2018 Apr; 19(1):58. PubMed ID: 29631548
[TBL] [Abstract][Full Text] [Related]
6. Genotyping single-nucleotide polymorphisms of human genes involved in organophosphate detoxification by high-resolution melting.
Kurdyukov I; Rodionov G; Radilov A; Babakov V
Anal Bioanal Chem; 2014 Aug; 406(21):5087-92. PubMed ID: 24705954
[TBL] [Abstract][Full Text] [Related]
7. Screening patients with prolonged neuromuscular blockade after succinylcholine and mivacurium.
Cerf C; Mesguish M; Gabriel I; Amselem S; Duvaldestin P
Anesth Analg; 2002 Feb; 94(2):461-6, table of contents. PubMed ID: 11812719
[TBL] [Abstract][Full Text] [Related]
8. Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population.
Yen T; Nightingale BN; Burns JC; Sullivan DR; Stewart PM
Clin Chem; 2003 Aug; 49(8):1297-308. PubMed ID: 12881446
[TBL] [Abstract][Full Text] [Related]
9. Timing of blood sampling for butyrylcholinesterase phenotyping in patients with prolonged neuromuscular block after mivacurium or suxamethonium.
Mintjens N; Brummans R; Soetens F; Claes KBM; Vanlinthout LE
Acta Anaesthesiol Scand; 2021 Feb; 65(2):182-187. PubMed ID: 33010031
[TBL] [Abstract][Full Text] [Related]
10. Novel mutations in the BCHE gene in patients with no butyrylcholinesterase activity.
On-Kei Chan A; Lam CW; Tong SF; Man Tung C; Yung K; Chan YW; Au KM; Yuen YP; Hung CT; Ng KP; Shek CC
Clin Chim Acta; 2005 Jan; 351(1-2):155-9. PubMed ID: 15563885
[TBL] [Abstract][Full Text] [Related]
11. Response to succinylcholine in patients carrying the K-variant of the butyrylcholinesterase gene.
Bretlau C; Sørensen MK; Vedersoe AL; Rasmussen LS; Gätke MR
Anesth Analg; 2013 Mar; 116(3):596-601. PubMed ID: 23400986
[TBL] [Abstract][Full Text] [Related]
12. Production of the butyrylcholinesterase knockout mouse.
Li B; Duysen EG; Saunders TL; Lockridge O
J Mol Neurosci; 2006; 30(1-2):193-5. PubMed ID: 17192674
[TBL] [Abstract][Full Text] [Related]
13. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.
Gätke MR; Bundgaard JR; Viby-Mogensen J
Pharmacogenet Genomics; 2007 Nov; 17(11):995-9. PubMed ID: 18075469
[TBL] [Abstract][Full Text] [Related]
14. Resequencing array for gene variant detection in malignant hyperthermia and butyrylcholinestherase deficiency.
Levano S; Gonzalez A; Singer M; Demougin P; Rüffert H; Urwyler A; Girard T
Neuromuscul Disord; 2017 May; 27(5):492-499. PubMed ID: 28259615
[TBL] [Abstract][Full Text] [Related]
15. Prolonged toxic effects after cocaine challenge in butyrylcholinesterase/plasma carboxylesterase double knockout mice: a model for butyrylcholinesterase-deficient humans.
Duysen EG; Lockridge O
Drug Metab Dispos; 2011 Aug; 39(8):1321-3. PubMed ID: 21540357
[TBL] [Abstract][Full Text] [Related]
16. Rapid simultaneous genotyping of the frequent butyrylcholinesterase variants Asp70Gly and Ala539Thr with fluorescent hybridization probes.
Gätke MR; Viby-Mogensen J; Bundgaard JR
Scand J Clin Lab Invest; 2002; 62(5):375-83. PubMed ID: 12387584
[TBL] [Abstract][Full Text] [Related]
17. Frequency of butyrylcholinesterase gene mutations in individuals with abnormal inhibition numbers: an Italian-population study.
Lando G; Mosca A; Bonora R; Azzario F; Penco S; Marocchi A; Panteghini M; Patrosso MC
Pharmacogenetics; 2003 May; 13(5):265-70. PubMed ID: 12724618
[TBL] [Abstract][Full Text] [Related]
18. Rapid identification of atypical variant of plasma butyrylcholinesterase by PCR.
Ceppa F; Gidenne S; Benois A; Fontan E; Burnat P
Clin Chem Lab Med; 2002 Aug; 40(8):799-801. PubMed ID: 12392308
[TBL] [Abstract][Full Text] [Related]
19. An Indian butyrylcholinesterase variant L307P is not structurally stable: a molecular dynamics simulation study.
David SM; Venkatesan SK; Boopathy R
Chem Biol Interact; 2013 Mar; 203(1):30-5. PubMed ID: 23123771
[TBL] [Abstract][Full Text] [Related]
20. Characterization of four BCHE mutations associated with prolonged effect of suxamethonium.
Brazzolotto X; Courcelle S; Sauvanet C; Guillon V; Igert A; Kononchik J; Nachon F; Ceppa F; Delacour H
Pharmacogenomics J; 2021 Apr; 21(2):165-173. PubMed ID: 33024248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
